337 related articles for article (PubMed ID: 24261359)
1. Usefulness of conventional MRI sequences and diffusion-weighted imaging in differentiating malignant from benign portal vein thrombus in cirrhotic patients.
Sandrasegaran K; Tahir B; Nutakki K; Akisik FM; Bodanapally U; Tann M; Chalasani N
AJR Am J Roentgenol; 2013 Dec; 201(6):1211-9. PubMed ID: 24261359
[TBL] [Abstract][Full Text] [Related]
2. MRI in differentiating malignant versus benign portal vein thrombosis in patients with hepatocellular carcinoma: Value of post contrast imaging with subtraction.
Gawande R; Jalaeian H; Niendorf E; Olgun D; Krystosek L; Rubin N; Spilseth B
Eur J Radiol; 2019 Sep; 118():88-95. PubMed ID: 31439264
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of malignant thrombus from bland thrombus of the portal vein in patients with hepatocellular carcinoma: application of diffusion-weighted MR imaging.
Catalano OA; Choy G; Zhu A; Hahn PF; Sahani DV
Radiology; 2010 Jan; 254(1):154-62. PubMed ID: 20032150
[TBL] [Abstract][Full Text] [Related]
4. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
Lee MH; Kim SH; Park MJ; Park CK; Rhim H
AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
[TBL] [Abstract][Full Text] [Related]
5. Diffusion-Weighted MRI of Malignant versus Benign Portal Vein Thrombosis.
Ahn JH; Yu JS; Cho ES; Chung JJ; Kim JH; Kim KW
Korean J Radiol; 2016; 17(4):533-40. PubMed ID: 27390544
[TBL] [Abstract][Full Text] [Related]
6. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
[TBL] [Abstract][Full Text] [Related]
7. Contrast-enhanced ultrasound in differentiating malignant from benign portal vein thrombosis in hepatocellular carcinoma.
Tarantino L; Ambrosino P; Di Minno MN
World J Gastroenterol; 2015 Aug; 21(32):9457-60. PubMed ID: 26327753
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of portal vein thrombosis discontinued with liver tumors in patients with liver cirrhosis and tumors by contrast-enhanced US: a pilot study.
Song ZZ; Huang M; Jiang TA; Zhao QY; Yao L; Mou Y; Zhao JK; Ao JY; Chen F; Chen Y
Eur J Radiol; 2010 Aug; 75(2):185-8. PubMed ID: 19464131
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic performances of intravoxel incoherent motion and conventional diffusion-weighted imaging in the differential diagnosis of benign and malignant portal vein thrombus.
Aumann EK; Server S; Koyuncu Sokmen B; Oz A; Namal E; Gurcan NI; Balci NC; Tokat Y
Abdom Radiol (NY); 2018 Sep; 43(9):2270-2276. PubMed ID: 29411058
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous ultrasound-guided fine-needle aspiration of portal vein thrombi as a diagnostic and staging technique for hepatocellular carcinoma.
Rammohan A; Jeswanth S; Sukumar R; Anand L; Kumar PS; Srinivasan UP; Ravi R; Ravichandran P
Abdom Imaging; 2013 Oct; 38(5):1057-60. PubMed ID: 23579929
[TBL] [Abstract][Full Text] [Related]
11. Portal Vein Thrombosis in Patients with Hepatocellular Carcinoma: Diagnostic Accuracy of Gadoxetic Acid-enhanced MR Imaging.
Kim JH; Lee JM; Yoon JH; Lee DH; Lee KB; Han JK; Choi BI
Radiology; 2016 Jun; 279(3):773-83. PubMed ID: 26780538
[TBL] [Abstract][Full Text] [Related]
12. Diffusion-weighted imaging of the liver in patients with chronic liver disease: comparison of monopolar and bipolar diffusion gradients for image quality and lesion detection.
Lewis S; Kamath A; Chatterji M; Patel A; Shyknevsky I; Dyvorne HA; Kuehn B; Taouli B
AJR Am J Roentgenol; 2015 Jan; 204(1):59-68. PubMed ID: 25539238
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of benign and malignant portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma: color Doppler US, contrast-enhanced US, and fine-needle biopsy.
Tarantino L; Francica G; Sordelli I; Esposito F; Giorgio A; Sorrentino P; de Stefano G; Di Sarno A; Ferraioli G; Sperlongano P
Abdom Imaging; 2006; 31(5):537-44. PubMed ID: 16865315
[TBL] [Abstract][Full Text] [Related]
14. Benign and malignant portal vein thrombosis: differentiation by CT characteristics.
Tublin ME; Dodd GD; Baron RL
AJR Am J Roentgenol; 1997 Mar; 168(3):719-23. PubMed ID: 9057522
[TBL] [Abstract][Full Text] [Related]
15. Infiltrative hepatocellular carcinoma: comparison of MRI sequences for lesion conspicuity.
Rosenkrantz AB; Lee L; Matza BW; Kim S
Clin Radiol; 2012 Dec; 67(12):e105-11. PubMed ID: 23026725
[TBL] [Abstract][Full Text] [Related]
16. Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (<= 2.0 cm) in patients with hepatitis-induced liver cirrhosis.
Park MJ; Kim YK; Lee MH; Lee JH
Acta Radiol; 2013 Mar; 54(2):127-36. PubMed ID: 23148300
[TBL] [Abstract][Full Text] [Related]
17. B-mode and contrast enhanced ultrasound guided biopsy of portal vein thrombosis. Value in the diagnosis of occult hepatocellular carcinoma in liver cirrhosis.
Sparchez Z; Radu P; Zaharia T; Kacso G; Diaconu B; Grigorescu I; Badea R
Med Ultrason; 2010 Dec; 12(4):286-94. PubMed ID: 21210013
[TBL] [Abstract][Full Text] [Related]
18. Added value of diffusion-weighted MRI for evaluating viable tumor of hepatocellular carcinomas treated with radiotherapy in patients with chronic liver disease.
Park HJ; Kim SH; Jang KM; Lim S; Kang TW; Park HC; Choi D
AJR Am J Roentgenol; 2014 Jan; 202(1):92-101. PubMed ID: 24370133
[TBL] [Abstract][Full Text] [Related]
19. Hypervascular hepatocellular carcinoma 1 cm or smaller in patients with chronic liver disease: characterization with gadoxetic acid-enhanced MRI that includes diffusion-weighted imaging.
Kim JE; Kim SH; Lee SJ; Rhim H
AJR Am J Roentgenol; 2011 Jun; 196(6):W758-65. PubMed ID: 21606265
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of bland from neoplastic thrombus of the portal vein in patients with hepatocellular carcinoma: application of susceptibility-weighted MR imaging.
Li C; Hu J; Zhou D; Zhao J; Ma K; Yin X; Wang J
BMC Cancer; 2014 Aug; 14():590. PubMed ID: 25123782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
